> top > docs > PubMed:33134948 > annotations

PubMed:33134948 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid_Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 765-772 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T2 765-772 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin
T3 871-878 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T4 871-878 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin
T5 1049-1056 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T6 1049-1056 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin
T7 1210-1217 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T8 1210-1217 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin
T9 1453-1460 https://glytoucan.org/Structures/Glycans/G00021MO denotes heparin
T10 1453-1460 https://glytoucan.org/Structures/Glycans/G54161DR denotes heparin

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 142-148 Body_part denotes Kidney http://purl.org/sig/ont/fma/fma7203
T2 765-772 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T3 871-878 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T4 1049-1056 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T5 1210-1217 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839
T6 1453-1460 Body_part denotes heparin http://purl.org/sig/ont/fma/fma82839

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 142-148 Body_part denotes Kidney http://purl.obolibrary.org/obo/UBERON_0002113

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 97-121 Disease denotes Coronavirus Disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T2 136-155 Disease denotes Acute Kidney Injury http://purl.obolibrary.org/obo/MONDO_0002492
T3 237-261 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T4 461-485 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T5 1345-1369 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 0-1 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T2 142-148 http://purl.obolibrary.org/obo/UBERON_0002113 denotes Kidney
T3 142-148 http://www.ebi.ac.uk/efo/EFO_0000927 denotes Kidney
T4 142-148 http://www.ebi.ac.uk/efo/EFO_0000929 denotes Kidney
T5 157-167 http://purl.obolibrary.org/obo/BFO_0000030 denotes Objectives
T6 437-439 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T7 447-449 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T8 623-624 http://purl.obolibrary.org/obo/CLO_0001020 denotes A

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 726-733 Chemical denotes citrate http://purl.obolibrary.org/obo/CHEBI_133748|http://purl.obolibrary.org/obo/CHEBI_16947|http://purl.obolibrary.org/obo/CHEBI_50744
T4 762-764 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T5 765-772 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T6 821-828 Chemical denotes citrate http://purl.obolibrary.org/obo/CHEBI_133748|http://purl.obolibrary.org/obo/CHEBI_16947|http://purl.obolibrary.org/obo/CHEBI_50744
T9 868-870 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T10 871-878 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T11 1008-1015 Chemical denotes citrate http://purl.obolibrary.org/obo/CHEBI_133748|http://purl.obolibrary.org/obo/CHEBI_16947|http://purl.obolibrary.org/obo/CHEBI_50744
T14 1046-1048 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T15 1049-1056 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T16 1160-1167 Chemical denotes citrate http://purl.obolibrary.org/obo/CHEBI_133748|http://purl.obolibrary.org/obo/CHEBI_16947|http://purl.obolibrary.org/obo/CHEBI_50744
T19 1207-1209 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T20 1210-1217 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T21 1403-1410 Chemical denotes citrate http://purl.obolibrary.org/obo/CHEBI_133748|http://purl.obolibrary.org/obo/CHEBI_16947|http://purl.obolibrary.org/obo/CHEBI_50744
T24 1450-1452 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T25 1453-1460 Chemical denotes heparin http://purl.obolibrary.org/obo/CHEBI_28304
T26 1544-1551 Chemical denotes citrate http://purl.obolibrary.org/obo/CHEBI_133748|http://purl.obolibrary.org/obo/CHEBI_16947|http://purl.obolibrary.org/obo/CHEBI_50744

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 136-155 Phenotype denotes Acute Kidney Injury http://purl.obolibrary.org/obo/HP_0001919

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 82-121 Disease denotes Critically Ill Coronavirus Disease 2019 MESH:C000657245
4 122-130 Species denotes Patients Tax:9606
5 136-155 Disease denotes Acute Kidney Injury MESH:D058186
27 237-261 Disease denotes coronavirus disease 2019 MESH:C000657245
28 262-270 Species denotes patients Tax:9606
29 395-403 Species denotes Patients Tax:9606
30 461-485 Disease denotes coronavirus disease 2019 MESH:C000657245
31 486-494 Species denotes patients Tax:9606
32 726-733 Chemical denotes citrate MESH:D019343
33 765-772 Chemical denotes heparin MESH:D006493
34 821-828 Chemical denotes citrate MESH:D019343
35 871-878 Chemical denotes heparin MESH:D006493
36 899-909 Chemical denotes nadroparin MESH:D017762
37 1008-1015 Chemical denotes citrate MESH:D019343
38 1049-1056 Chemical denotes heparin MESH:D006493
39 1160-1167 Chemical denotes citrate MESH:D019343
40 1210-1217 Chemical denotes heparin MESH:D006493
41 1238-1248 Chemical denotes nadroparin MESH:D017762
42 1345-1369 Disease denotes coronavirus disease 2019 MESH:C000657245
43 1374-1382 Species denotes patients Tax:9606
44 1403-1410 Chemical denotes citrate MESH:D019343
45 1453-1460 Chemical denotes heparin MESH:D006493
46 1481-1491 Chemical denotes nadroparin MESH:D017762
47 1544-1551 Chemical denotes citrate MESH:D019343

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-156 Sentence denotes A Method to Improve Continuous Renal Replacement Therapy Circuit Survival Time in Critically Ill Coronavirus Disease 2019 Patients With Acute Kidney Injury.
T2 157-168 Sentence denotes Objectives:
T3 169-291 Sentence denotes Optimizing continuous renal replacement therapy circuit survival in coronavirus disease 2019 patients admitted to the ICU.
T4 292-299 Sentence denotes Design:
T5 300-353 Sentence denotes Single-center prospective observational cohort study.
T6 354-362 Sentence denotes Setting:
T7 363-394 Sentence denotes Tertiary academic teaching ICU.
T8 395-404 Sentence denotes Patients:
T9 405-607 Sentence denotes Between March 19, 2020, and May 18, 2020, 11 out of 101 coronavirus disease 2019 patients were treated with continuous renal replacement therapy comprising 127 continuous renal replacement therapy days.
T10 608-622 Sentence denotes Interventions:
T11 623-910 Sentence denotes A nonrandomized observational comparison of circuit anticoagulation modalities using standard regional citrate anticoagulation, continuous IV heparin anticoagulation, or the combination of regional citrate anticoagulation with either continuous IV heparin or therapeutic dose nadroparin.
T12 911-941 Sentence denotes Measurements and Main Results:
T13 942-1073 Sentence denotes Circuit patency was shorter than 24 hours using standard regional citrate anticoagulation or continuous IV heparin anticoagulation.
T14 1074-1261 Sentence denotes Median circuit survival increased with at least 165% when the combination of regional citrate anticoagulation with either continuous IV heparin or therapeutic dose nadroparin was applied.
T15 1262-1274 Sentence denotes Conclusions:
T16 1275-1383 Sentence denotes Continuous renal replacement therapy circuit patency is diminished in coronavirus disease 2019 ICU patients.
T17 1384-1616 Sentence denotes Combining regional citrate anticoagulation with either continuous IV heparin or therapeutic dose nadroparin increases filter survival as compared with regional citrate anticoagulation alone in this nonrandomized observational study.